BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30270696)

  • 1. Anti-citrullinated protein antibodies and arthritis in Sjögren's syndrome: a systematic review and meta-analysis.
    Molano-González N; Olivares-Martínez E; Anaya JM; Hernández-Molina G
    Scand J Rheumatol; 2019 Mar; 48(2):157-163. PubMed ID: 30270696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of novel autoantibody isotypes against citrullinated-inter-alpha-trypsin inhibitor heavy chain 3 (ITIH3)(542-556) peptide in serum from Taiwanese females with rheumatoid arthritis, primary Sjögren's syndrome and secondary Sjögren's syndrome in rheumatoid arthritis.
    Liao CC; Chou PL; Cheng CW; Chang YS; Chi WM; Tsai KL; Chen WJ; Kung TS; Tai CC; Lee KW; Chen YC; Lin CY
    J Proteomics; 2016 Jun; 141():1-11. PubMed ID: 27072115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against citrullinated alpha enolase peptides in primary Sjogren's syndrome.
    Nezos A; Cinoku I; Mavragani CP; Moutsopoulos HM
    Clin Immunol; 2017 Oct; 183():300-303. PubMed ID: 28919520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. α-enolase is an antigenic target in primary Sjögren's syndrome.
    Olivares-Martínez E; Hernández-Ramírez DF; Núñez-Álvarez CA; Llorente L; Hernandez-Molina G
    Clin Exp Rheumatol; 2019; 37 Suppl 118(3):29-35. PubMed ID: 30418121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence and significance of immunoglobulin G-anti-cyclic citrullinated peptide antibodies in primary Sjogren's syndrome patients].
    Liu Y; Wang YF; Wang KL; Lv FF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):478-82. PubMed ID: 24943033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of anti-cyclic citrullinated peptide and anti-keratin antibodies in patients with primary Sjögren's syndrome.
    Gottenberg JE; Mignot S; Nicaise-Rolland P; Cohen-Solal J; Aucouturier F; Goetz J; Labarre C; Meyer O; Sibilia J; Mariette X
    Ann Rheum Dis; 2005 Jan; 64(1):114-7. PubMed ID: 15231509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterizing hand and wrist ultrasound pattern in primary Sjögren's syndrome: a case-control study.
    Guedes LKN; Leon EP; Bocate TS; Bonfigliolli KR; Lourenço SV; Bonfa E; Pasoto SG
    Clin Rheumatol; 2020 Jun; 39(6):1907-1918. PubMed ID: 32072351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyarthritis in primary Sjögren's syndrome represents a distinct subset with less pronounced B cell proliferation a Dutch cohort with long-term follow-up.
    ter Borg EJ; Kelder JC
    Clin Rheumatol; 2016 Mar; 35(3):649-55. PubMed ID: 26791875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The findings of musculoskeletal ultrasonography on primary Sjögren's syndrome patients in childhood with articular manifestations and the impact of anti-cyclic citrullinated peptide antibody.
    Shabana K; Okamoto N; Sugita Y; Shindo K; Murata T; Tamai H; Fujiwara K
    Mod Rheumatol; 2019 Sep; 29(5):821-828. PubMed ID: 30289018
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis.
    Kamali S; Polat NG; Kasapoglu E; Gul A; Ocal L; Aral O; Konice M; Badur S; Inanc M
    Clin Rheumatol; 2005 Nov; 24(6):673-6. PubMed ID: 15926038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follow-up of primary Sjogren's syndrome patients presenting positive anti-cyclic citrullinated peptides antibody.
    Ryu YS; Park SH; Lee J; Kwok SK; Ju JH; Kim HY; Jeon CH
    Rheumatol Int; 2013 Jun; 33(6):1443-6. PubMed ID: 23179261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of IgA class antibodies to cyclic citrullinated peptide (anti-CCP) in patients with primary Sjögren's syndrome, and its association to clinical manifestations.
    Haga HJ; Andersen DT; Peen E
    Clin Rheumatol; 2011 Mar; 30(3):369-72. PubMed ID: 21234630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
    Payet J; Belkhir R; Gottenberg JE; Bergé E; Desmoulins F; Meyer O; Mariette X; Seror R
    RMD Open; 2015; 1(1):e000066. PubMed ID: 26509066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against carbamylated proteins: prevalence and associated disease characteristics in Belgian patients with rheumatoid arthritis or other rheumatic diseases.
    Sidiras P; Spruyt D; Gangji V; Imbault V; Sokolova T; Durez P; Communi D; Rasschaert J; Badot V
    Scand J Rheumatol; 2021 Mar; 50(2):118-123. PubMed ID: 33025839
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoantibodies against gliadin in rheumatoid arthritis and primary Sjögren's syndrome patients.
    Koszarny A; Majdan M; Suszek D; Dryglewska M; Tabarkiewicz J
    Wiad Lek; 2015; 68(3):242-7. PubMed ID: 26753207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of muscarinic acetylcholine receptor type 3 polypeptide (M3RP205-220) antibody in the saliva of patients with primary Sjögren's syndrome.
    He J; Qiang L; Ding Y; Wei P; Li YN; Hua H; Li ZG
    Clin Exp Rheumatol; 2012; 30(3):322-6. PubMed ID: 22510450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arthritis in primary Sjögren's syndrome: Characteristics, outcome and treatment from French multicenter retrospective study.
    Mirouse A; Seror R; Vicaut E; Mariette X; Dougados M; Fauchais AL; Deroux A; Dellal A; Costedoat-Chalumeau N; Denis G; Sellam J; Arlet JB; Lavigne C; Urbanski G; Fischer-Dumont D; Diallo A; Fain O; Mékinian A;
    Autoimmun Rev; 2019 Jan; 18(1):9-14. PubMed ID: 30408585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-cyclic citrullinated peptide antibodies in primary Sjögren syndrome may be associated with non-erosive synovitis.
    Atzeni F; Sarzi-Puttini P; Lama N; Bonacci E; Bobbio-Pallavicini F; Montecucco C; Caporali R
    Arthritis Res Ther; 2008; 10(3):R51. PubMed ID: 18462485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of autoantibodies recognizing Sjögren's syndrome A (SSA), SSB, calpastatin and alpha-fodrin in primary Sjögren's syndrome.
    Goëb V; Salle V; Duhaut P; Jouen F; Smail A; Ducroix JP; Tron F; Le Loët X; Vittecoq O
    Clin Exp Immunol; 2007 May; 148(2):281-7. PubMed ID: 17286756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide antibody-positive rheumatoid arthritis caused by bacterial organizing pneumonia in a patient with Sjogren's syndrome.
    Horino T; Yoshida M; Inotani S; Anabuki K; Ohnishi H; Komori M; Ichii O; Terada Y
    Rom J Intern Med; 2022 Jun; 60(2):127-131. PubMed ID: 35092658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.